Invasive Saccharomyces Infection: A Comprehensive Review
The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Saccharomyces cerevisiae (also known as "baker's yeast" or "brewer's yeast") is mostly considered to be an occasional digestive commensal. However, since the 1990s, there have been a growing number of reports about its implication as an etiologic agent of invasive infection. A particular feature of such infections is their association with a probiotic preparation of Saccharomyces boulardii (a subtype of S. cerevisiae) for treatment various diarrheal disorders. METHODS: We collected published case reports, through May 2005, of invasive Saccharomyces infection by use of a Medline query. Epidemiological and clinical charts and therapeutic strategies were analyzed. RESULTS: We found 92 cases of Saccharomyces invasive infection. Predisposing factors were similar to those of invasive candidiasis, with intravascular catheter and antibiotic therapy being the most frequent. Blood was the most frequent site of isolation (for 72 patients). S. boulardii accounted for 51.3% of fungemias and was exclusively isolated from blood. Compared with patients infected with S. cerevisiae, patients infected with S. boulardii were more frequently immunocompetent and had a better prognosis. Saccharomyces invasive infection was clinically indistinguishable from an invasive candidiasis. Overall, S. cerevisiae clinical isolates exhibited low susceptibility to amphotericin B and azole derivatives. However, global outcome was favorable in 62% of the cases. Treatment with intravenous amphotericin B and fluconazole, in combination with central vascular catheter removal, were effective therapeutic options. CONCLUSION: Saccharomyces organisms should now be added to the growing list of emerging fungal pathogens. Special caution should be taken regarding the use of S. boulardii probiotic preparations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple cases of disseminated infection have been identified in apparent association with this probiotic, particularly in immune-suppressed individuals (39).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [39]
In the citing paper
“In a few case studies, however, S. cerevisiae has been implicated in catheter-associated infections with mixed-species biofilms in patients in intensive care units (ICUs)”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
In the citing paper
“and it is able to form a thin biofilm consisting of round, budding yeast-form cells and pseudohyphal cells in vitro (26, 50, 128, 164).”
From Candida albicans Biofilms and Human Disease (2015) · cites this paper as [50]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 1×
“We only considered proven infection, based on the definitions of the Invasive Fungal Infection Cooperative Group of the European Organization for Research and Treatment of Cancer–Mycosis Study Group of the National Institute of Allergy and Infectious Diseases cooperative group [19]: fungemia, isolation from normally s…”
MethodNEW YORK STATE JOURNAL OF MEDICINE.
(1901) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1901.02470020041007 · Cited by 1,472
Rex, J. H., Pfaller, M. A., Galgiani, J. N., Bartlett, M. S., Espinel-Ingroff, A., Ghannoum, M. A., Lancaster, M., Odds, F. C., Rinaldi, M. G., Walsh, T. J., et al. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.2.235 · Cited by 855
Medical Mycology. The Pathogenic Fungi and Pathogenic Actinomycetes.
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-84-4-514_1 · Cited by 847
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 1×
“Despite this spectrum of susceptibility, a favorable outcome was observed in 63% of cases revealed in our literature search, which is a slightly higher percentage than that reported for cases of invasive candidiasis [87].”
ResultProtection from gastrointestinal diseases with the use of probiotics
Marteau, P. R., Vrese, M. D., Cellier, C. J., & Schrezenmeir, J. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.430s · Cited by 596
Saccharomyces cerevisiae Fungemia: An Emerging Infectious Disease
Munoz, P., Bouza, E., Cuenca-Estrella, M., Eiros, J. M., Perez, M. J., Sanchez-Somolinos, M., Rincon, C., Hortal, J., & Pelaez, T. (2005) · Clinical Infectious Diseases · doi:10.1086/429916 · Cited by 462 · cited 1×
“35[77] 76 years, F DNA fingerprinting Diabetes, heart surgery No Yes Yes Yes FLU NS Death 36 [771 72 years, F DNA fingerprinting Heart surgery No Yes Yes Yes None NS Death 37 [77] 74 years, F DNA fingerprinting Rheumatoid arthritis, corticosteroid therapy, heart surgery NS No Yes Yes FLU NS Death”
BackgroundFUNGAL ENDOCARDITIS: ANALYSIS OF 24 CASES AND REVIEW OF THE LITERATURE
EUBINSTE1N, E., NOKIEGA, E. R., SIMBEEKOFF, M. S., HOLZMAN, E., & RAHAL, J. J. (1975) · Medicine · doi:10.1097/00005792-197507000-00003 · Cited by 275 · cited 1×
“1 [231 54 years, F Blood Urine Diphtheroids Valvular prosthesis No Yes Yes AmB Yes Favorable 2 [24] 38 years, M .”
BackgroundNew Spectrum of Fungal Infections in Patients with Cancer
Anaissie, E., Bodey, G. P., Kantarjian, H., Ro, J., Vartivarian, S. E., Hopfer, R., Hoy, J., & Rolston, K. (1989) · Clinical Infectious Diseases · doi:10.1093/clinids/11.3.369 · Cited by 259
Possible Role of Catheters in Saccharomyces boulardii Fungemia
Hennequin, C., Kauffmann-Lacroix, C., Jobert, A., Viard, J. P., Ricour, C., Jacquemin, J. L., & Berche, P. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960050003 · Cited by 253 · cited 5×
“Hand transmission has been suggested in these latter cases [5].”
BackgroundMethodInfluentialSelf-citationSeven cases of fungemia with Saccharomyces boulardii in critically ill patients
Lherm, T., Monet, C., Nougière, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., & Malbrunot, C. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1267-9 · Cited by 238 · cited 4×
“Invasive Saccharomyces Infection • CID 2005:41 (1 December) • 1565 a likely portal of entry because of possible contamination through hand transmission [6, 7].”
BackgroundMethodInfluentialCassone, M., Serra, P., Mondello, F., Girolamo, A., Scafetti, S., Pistella, E., & Venditti, M. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.11.5340-5343.2003 · Cited by 215 · cited 3×
“Patients with insufficient clinical information were excluded [7, 18].”
BackgroundMethodMicrosatellite Typing as a New Tool for Identification of Saccharomyces cerevisiae Strains
Hennequin, C., Thierry, A., Richard, G. F., Lecointre, G., Nguyen, H. V., Gaillardin, C., & Dujon, B. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.2.551-559.2001 · Cited by 206 · cited 1×
“[10] on 67 S.”
Self-citationThe Spectrum of Non-Candida Fungal Infections following Bone Marrow Transplantation
MORRISON, V. A., HAAKE, R. J., & WEISDORF, D. J. (1993) · Medicine · doi:10.1097/00005792-199303000-00002 · Cited by 179 · cited 2×
“None CAPD NS Yes No FLU Yes Favorable 48 [49] 36 years, M Lungc .”
BackgroundRiquelme, A. J., Calvo, M. A., Guzmán, A. M., Depix, M. S., García, P., Pérez, C., Arrese, M., & Labarca, J. A. (2003) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200301000-00013 · Cited by 166 · cited 1×
“difficile diarrhea NS NS Yes Yes FLU NS Favorable 31 [73] 41 years, M PFGE karyotyping plus RFLP AIDS NS NS Yes Yes AmB NS Favorable 32 [74] 89 years, F ND Intestinal disease No No Yes Yes FLU No Death 33 [75] 65 years, M ND Head and neck cancer, intestinal disease Yes Yes Yes Yes AmB Yes Favorable 34 [76] 19 years, M…”
BackgroundRl, S. (1995) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(96)82652-7 · Cited by 159
Species Identification and Virulence Attributes of Saccharomyces boulardii (nom. inval.)
McCullough, M. J., Clemons, K. V., McCusker, J. H., & Stevens, D. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.9.2613-2617.1998 · Cited by 139 · cited 2×
“boulardii showed an intermediate level of virulence in an experimental murine model of invasive infection involving both immunocompetent and immunocompromised mice [3].”
BackgroundInvasive infection with Saccharomyces cerevisiae: report of three cases and review
Aucott, J. N., Fayen, J., Grossnicklas, H., Morrissey, A., Lederman, M. M., & Salata, R. A. (1990) · Clinical Infectious Diseases · doi:10.1093/clinids/12.3.406 · Cited by 137
Vaginitis due to Saccharomyces cerevisiae: epidemiology, clinical aspects and therapy
Sobel, J. D., Vazquez, J., Lynch, M., Meriwether, C., & Zervos, M. J. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.1.93 · Cited by 117 · cited 1×
“4% of cases [14, 15].”
McCusker, J. H., Clemons, K. V., Stevens, D. A., & Davis, R. W. (1994) · Infection and Immunity · doi:10.1128/iai.62.12.5447-5455.1994 · Cited by 116 · cited 2×
“cerevisiae that distinguish between environmental and clinical strains on the basis of virulence-related phenotype [84].”
BackgroundSurgical and long-term antifungal therapy for fungal prosthetic valve endocarditis
Muehrcke, D. D., Lytle, B. W., & Cosgrove, D. M. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00469-2 · Cited by 110 · cited 1×
“None Allogenic BMT for CML No Yes NS FLU Yes Favorable 19 [37] NS, NS Endocarditisc Blood NS Prosthetic valve NS Yes Yes AmB NS Favorable 20 [38] 32 years, F Blood .”
BackgroundSaccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii
Cesaro, S., Chinello, P., Rossi, L., & Zanesco, L. (2000) · Supportive Care in Cancer · doi:10.1007/s005200000123 · Cited by 109
Fungemia with Saccharomyces cerevisiae after treatment with Saccharomyces boulardii
Bassetti, S., Frei, R., & Zimmerli, W. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00133-8 · Cited by 103
Perapoch, J., Planes, A. M., Querol, A., L�pez, V. N., Mart�nez-Benday�n, I., Tormo, R., Fern�ndez, F., Peguero, G., & Salcedo, S. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000295 · Cited by 102
Fungemia with Saccharomyces boulardii in a 1‐Year‐Old Girl with Protracted Diarrhea
Pletincx, M., Legein, J., & Vandenplas, Y. (1995) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1995.tb11747.x · Cited by 102
Yoshida, M., Obayashi, T., Iwama, A., Ito, M., Tsunoda, S., Suzuki, T., Muroi, K., Ohta, M., Sakamoto, S., & Miura, Y. (1997) · Medical Mycology · doi:10.1080/02681219780001441 · Cited by 101
A Saccharomyces cerevisiae mutant with increased virulence
Wheeler, R. T., Kupiec, M., Magnelli, P., Abeijon, C., & Fink, G. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437995100 · Cited by 99 · cited 3×
“cerevisiae showed similar virulence in a mouse model of infection [85].”
BackgroundInfluentialPfaller, M. A., Messer, S., & Jones, R. N. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.233 · Cited by 92 · cited 4×
“25 74 [78, 79] 0.”
InfluentialSparrelid, E., Hägglund, H., Remberger, M., Ringdén, O., Lönnqvist, B., Ljungman, P., & Andersson, J. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701404 · Cited by 91 · cited 1×
“None Relapsed ALL Yes NS Yes AmB, 5-FCa NS Favorable 25 [42] NS, NS Blood .”
BackgroundSaccharomyces cerevisiae pneumonia in a patient with acquired immune deficiency syndrome
Tawfik, O. W., Papasian, C. J., Dixon, A. Y., & Potter, L. M. (1989) · Journal of Clinical Microbiology · doi:10.1128/jcm.27.7.1689-1691.1989 · Cited by 90
Pfaller, M. A., Messer, S. A., & Coffman, S. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.763 · Cited by 85 · cited 4×
“25 74 [78, 79] 0.”
InfluentialAre live saccharom yces yeasts harmful to patients?
Piarroux, R., Millon, L., Bardonnet, K., Vagner, O., & Koenig, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)02001-2 · Cited by 77 · cited 1×
“6% among patients at French teaching hospitals [9].”
BackgroundSaccharomyces cerevisiae infections in man
Eng, R. H. K., Drehmel, R., Smith, S. M., & Goldstein, E. J. C. (1984) · Medical Mycology · doi:10.1080/00362178485380651 · Cited by 74 · cited 1×
“, pleural and synovial fluids), and deep-site infections either histologically proven for sites susceptible to colonization (lungs, peritoneum, esophagus) [20, 21].”
BackgroundFungemia Due to Saccharomyces Species in a Patient Treated with Enteral Saccharomyces boulardii
Niault, M., Thomas, F., Prost, J., Ansari, F. H., & Kalfon, P. (1999) · Clinical Infectious Diseases · doi:10.1086/517255 · Cited by 72
Saccharomyces cerevisiae Septicemia
Eschete, M. L., & West, B. C. (1980) · Archives of Internal Medicine · doi:10.1001/archinte.140.11.1539 · Cited by 65
Rijnders, B. J. A., Wijngaerden, E. V., Verwaest, C., & Peetermans, W. E. (2000) · Intensive Care Medicine · doi:10.1007/s001340051261 · Cited by 63
Salonen, J. H., Richardson, M. D., Gallacher, K., Issakainen, J., Helenius, H. Y. M., Lehtonen, O. ‐., & NIKOSKELAINEN, J. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0718 · Cited by 62 · cited 3×
“This is also supported by the increasing rates of colonization among hospitalized patients with hematologic disease who only ingest sterile food not comprised of raw fruits or vegetables [16].”
BackgroundSaccharomyces cerevisiae fungemia: Case report and review of the literature
Cimolai, N., Gill, M. J., & Church, D. L. (1987) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(87)90158-1 · Cited by 60
Epidemiological Investigation of Vaginal Saccharomyces cerevisiae Isolates by a Genotypic Method
McCullough, M. J., Clemons, K. V., Farina, C., McCusker, J. H., & Stevens, D. A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.2.557-562.1998 · Cited by 59
Trends and sources of nosocomial fungaemia: Trends und Ursprünge nosokomialer Fungämien
Taylor, G. D., Buchanan‐Chell, M., Kirkland, T., & McKenzie, M. (1994) · Mycoses · doi:10.1111/j.1439-0507.1994.tb00298.x · Cited by 57 · cited 2×
“Patients with insufficient clinical information were excluded [7, 18].”
BackgroundOpportunistic Osteomyelitis in the Jaws of Children on Immunosuppressive Chemotherapy
Hovi, L., Saarinen, U. M., Donner, U., & Lindqvist, C. M. (1996) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199602000-00018 · Cited by 55 · cited 1×
“In these cases, yeasts were most often associated with necrosis [60] and granulomatous reaction [25].”
BackgroundIn vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates
Zerva, L., Hollis, R. J., & Pfaller, M. A. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.12.3031-3034.1996 · Cited by 54 · cited 3×
“cerevisiae was isolated only once, despite weekly surveillance cultures (primarily of stool and throat swab specimens) during hospitalization [17].”
BackgroundSaccharomyces cerevisiae septicemia.
Eschete, M. L., & West, B. C. (1980) · PubMed · Cited by 53
Swinne, D., Watelle, M., Van der Flaes, M., & Nolard, N. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00971.x · Cited by 52
Fatal Saccharomyces cerevisiae Aortic Graft Infection
Smith, D. M., Metzgar, D., Wills, C. J., & Fierer, J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.7.2691-2692.2002 · Cited by 51 · cited 1×
“NS Allogenic BMT for CML NS NS NS AmB NS Favorable 35 [501 57 years, F Blood Endocarditisc None Prosthetic valve No No Yes KET No, VR Death 36 [51] 56 years, M Blood .”
BackgroundFever of Unknown Origin Secondary to Brewer's Yeast Ingestion
Jensen, D. P. (1976) · Archives of Internal Medicine · doi:10.1001/archinte.1976.03630030064011 · Cited by 51 · cited 2×
“In these cases, yeasts were most often associated with necrosis [60] and granulomatous reaction [25].”
BackgroundSaccharomyces boulardii Fungemia in a Patient Receiving Ultra‐levure Therapy
Fredenucci, I., Chomarat, M., Boucaud, C., & Flandrois, J. P. (1998) · Clinical Infectious Diseases · doi:10.1086/517685 · Cited by 51 · cited 1×
“Although restriction-enzyme analysis of mitochondrial DNA [5, 6] or karyotyping [7, 8] are the tests most frequently used to identify S.”
MethodSACCHAROMYCES CEREVISIAE FUNGEMIA IN AN ELDERLY PATIENT WITH CLOSTRIDIUM DIFFICILE COLITIS
Cherifi, S., Robberecht, J., & Miendje, Y. (2004) · Acta Clinica Belgica · doi:10.1179/acb.2004.033 · Cited by 49 · cited 1×
“difficile diarrhea NS NS Yes Yes FLU NS Favorable 31 [73] 41 years, M PFGE karyotyping plus RFLP AIDS NS NS Yes Yes AmB NS Favorable 32 [74] 89 years, F ND Intestinal disease No No Yes Yes FLU No Death 33 [75] 65 years, M ND Head and neck cancer, intestinal disease Yes Yes Yes Yes AmB Yes Favorable 34 [76] 19 years, M…”
BackgroundFungämie nach oraler Gabe von Saccharomyces boulardii bei einem multimorbiden Patienten
(2003) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2003-44948 · Cited by 47
Fongémie à Saccharomyces boulardii chez un brûlé grave
Viggiano, M., Badetti, C., Bernini, V., Garabedian, M., & Manelli, J. C. (1995) · Annales Françaises d Anesthésie et de Réanimation · doi:10.1016/s0750-7658(05)80603-3 · Cited by 45
Fungemia with Saccharomycetaceae: Report of four Cases and Review of the Literature
Nielsen, H., Stenderup, J., & Bruun, B. (1990) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549009027100 · Cited by 45
[Saccharomyces boulardii fungemia. Apropos of a case].
Zunic, P., Lacotte, J., Pegoix, M., Buteux, G., Leroy, G., Mosquet, B., & Moulin, M. (1991) · PubMed · Cited by 41
Stein, P. D., Folkens, A. T., & Hruska, K. A. (1970) · CHEST Journal · doi:10.1378/chest.58.2.173 · Cited by 38
Burkhardt, O., Köhnlein, T., Pletz, M. W., & Welte, T. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540510026454 · Cited by 37 · cited 1×
“boulardii who did not respond to initial treatment with fluconazole [76].”
BackgroundPostoperative Peritonitis Caused by Saccharomyces cerevisiae
DOUGHERTY, S. H. (1982) · Archives of Surgery · doi:10.1001/archsurg.1982.01380260114019 · Cited by 36
Henry, S., D’Hondt, L., André, M., Holemans, X., & Canon, J. L. (2004) · Acta Clinica Belgica · doi:10.1179/acb.2004.032 · Cited by 36 · cited 1×
“difficile diarrhea NS NS Yes Yes FLU NS Favorable 31 [73] 41 years, M PFGE karyotyping plus RFLP AIDS NS NS Yes Yes AmB NS Favorable 32 [74] 89 years, F ND Intestinal disease No No Yes Yes FLU No Death 33 [75] 65 years, M ND Head and neck cancer, intestinal disease Yes Yes Yes Yes AmB Yes Favorable 34 [76] 19 years, M…”
BackgroundSaccharomyces fungemia in a patient with AIDS
Sethi, N., & Mandell, W. (1989) · Springer eBooks · doi:10.1007/978-1-4613-0807-2_40 · Cited by 36
Molecular and Epidemiological Characterization of Vaginal Saccharomyces cerevisiae Isolates
Posteraro, B., Sanguinetti, M., D’Amore, G., Masucci, L., Morace, G., & Fadda, G. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2230-2235.1999 · Cited by 34 · cited 1×
“1562 • CID 2005:41 (1 December) • Enache-Angoulvan and Hennequin of women) [12, 13], and S.”
Saccharomyces cervisiae septicemia in septicemia in a patient with myelodsplastic syndrome
Oriol, A., Ribera, J., Arnal, J., Millá, F., Batlle, M., & Feliú, E. (1993) · American Journal of Hematology · doi:10.1002/ajh.2830430424 · Cited by 34
Identification of yeasts in public hospital primary care patients with or without clinical vaginitis
Erdem, H., Çetin, M., Timuroğlu, T., Çetin, A., Yanar, O., & Pahsa, A. (2003) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1046/j.0004-8666.2003.00089.x · Cited by 33 · cited 1×
“1562 • CID 2005:41 (1 December) • Enache-Angoulvan and Hennequin of women) [12, 13], and S.”
Tiballi, R. N., Spiegel, J. E., Zarins, L. T., & Kauffman, C. A. (1995) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(95)00188-3 · Cited by 31 · cited 1×
“We did not include asymptomatic patients with only 1 organism isolated from the peritoneal cavity after digestive perforation or surgery, or from urine, oral swab, stool, or vaginal swab specimens, because such patients were more likely to have colonization rather than true infection [20–22].”
BackgroundChertow, G. M., Marcantonio, E. R., & Wells, R. G. (1991) · CHEST Journal · doi:10.1378/chest.99.6.1518 · Cited by 31
Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients
Olver, W. J., James, S. A., Lennard, A. L., Galloway, A., Roberts, I. N., Boswell, T. C., & Russell, N. H. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1314 · Cited by 29 · cited 1×
“, pleural and synovial fluids), and deep-site infections either histologically proven for sites susceptible to colonization (lungs, peritoneum, esophagus) [20, 21].”
BackgroundSACCHAROMYCES CEREVISIAE INFECTION IN A PATIENT WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
&NA; (1990) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199011000-00015 · Cited by 26
Saccharomyces cerevisiae fungemia with granulomas in the bone marrow in a patient undergoing BMT.
Cairoli, R., Marenco, P., Perego, R., & Cataldo, F. (1995) · PubMed · Cited by 24
Observation of Saccharomyces cerevisiae in blood of patient undergoing root canal treatment
Debelian, G., Olsen, I., & Tronstad, L. (1997) · International Endodontic Journal · doi:10.1046/j.1365-2591.1997.00101.x · Cited by 21
Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida
Lungarotti, M. S., Mezzetti, D., & Radicioni, M. (2003) · Archives of Disease in Childhood - Fetal and Neonatal Edition · doi:10.1136/fn.88.5.f446 · Cited by 20
SACCHAROMYCES CEREVISIAE INFECTIONS IN CHILDREN
Fiore, N. F., Conway, J. H., West, K. W., & Kleiman, M. B. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199812000-00022 · Cited by 20 · cited 2×
“NS BMT NS Yes NS NS NS NS 26 [43] 10 years, F Blood Lung,c mitral valvec None Cystic-fibrosis, intestinal obstruction, NS Yes Yes AmB Yes Death ileostomy 27 [43] 10 weeks, NS Blood .”
BackgroundIn vitroactivity of five antifungal agents against clinical isolates ofSaccharomyces cerevisiae
Barchiesi, F., Arzeni, D., Compagnucci, P., Francesco, L. F. D., Giacometti, A., & Scalise, G. (1998) · Medical Mycology · doi:10.1080/02681219880000701 · Cited by 19 · cited 7×
“25 30 [81] 0.”
InfluentialGreer, A. E., & Gemoets, H. N. (1943) · Diseases of the Chest · doi:10.1378/chest.9.3.212 · Cited by 18
Saccharomyces cerevisiae Sepsis in a 35-Week-Old Premature Infant. A Case Report
Ipson, M. A., & Blanco, C. L. (2001) · Journal of Perinatology · doi:10.1038/sj.jp.7200497 · Cited by 18
Zhanel, G. G., Karlowsky, J. A., Zelenitsky, S. A., Turik, M. A., & Hoban, D. J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2446 · Cited by 18 · cited 1×
“25–16 8 16 160 [83] 1–64 64 ND 104 Ketoconazole [80] 0.”
[Profound mycoses in AIDS in Abidjan (Côte d'Ivoire)].
Eholié, S. P., N'gbocho, L., Bissagnené, E., Coulibaly, M., Ehui, E., Kra, O., Assoumou, A., Aoussi, E., & Kadio, A. (1997) · PubMed · Cited by 15
Endocarditis verrucosa secundaria a Saccharomyces cerevisiae: Caso clínico
Fernando Ruiz-Esquide, E., María Cristina Díaz, J., Elba Wu, H., & Silva, V. (2002) · Revista médica de Chile · doi:10.4067/s0034-98872002001000012 · Cited by 14
Saccharomyces cerevisiae Fungemia in a Multiply Traumatized Patient
Manzella, J. P., Shaffer, S. N., AGARWAL, N., & Kellogg, J. A. (1989) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-198901000-00032 · Cited by 13 · cited 1×
“NS AML Yes NS NS AmB NS Favorable 9 [30] 25 years, F Blood .”
BackgroundPeritonitis Due to Saccharomyces Cerevisiae in a Patient on Capd
Snyder, S. M. (1992) · Peritoneal Dialysis International · doi:10.1177/089686089201200117 · Cited by 12 · cited 1×
“Coagulase-negative AML, chemotherapy Yes NS No AmB then KET NS NS staphylococci 46 [571 60 years, F Pleural fluid Sputum None Cirrhosis, esophagopleural fistula No NS No AmB NS Death 47 [58] 33 years, M Peritoneumc .”
BackgroundMoreno, A. R., Sánchez, M. A., Castillo, J. C., Rubio, J. R. S., Belsúe, F. V., & Calvo, F. T. (2000) · Revista Española de Cardiología · doi:10.1016/s0300-8932(00)75120-7 · Cited by 12
Ren, P., Sridhar, S. R., & Chaturvedi, V. P. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2840-2842.2004 · Cited by 12
Disseminated Saccharomyces cerevisiae infection following polymicrobial hepatobiliary sepsis
Heath, C. H., Jaksic, A. S., Mckerracher, D., & Clarke, G. M. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb02070.x · Cited by 11
Saccharomyces Cerevisiae Oesophagitis in an HIV-Infected Patient
Koneçny, P., Drummond, F., Tish, K. N., & TAPSALL, J. W. (1999) · International Journal of STD & AIDS · doi:10.1258/0956462991913475 · Cited by 10 · cited 1×
“NS Trauma, keratitis, endophthalmitis No NS NS AmB then Surgery Favorable abs essc FLU, A B irrigation 53 [62] 59 years, M Esophagitis0 .”
BackgroundSelf-inflicted Bacteraemia and Fungaemia in Vietnamese Migrants
Fung, K. S. C., Scheel, O., Lyon, D. J., Cheng, A. F., & Bendeck, J. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609027155 · Cited by 10 · cited 2×
“None Right breast abscess, septic shock NS NS NS NS NS Favorable 21 [38] 16 years, M Blood .”
BackgroundBilateral Ureteral Obstruction Due to Saccharomyces cerevisiae Fungus Balls
Senneville, É., Ajana, F. Z., Gerard, Y., Bourez, J. M., Alfandari, S., Chidiac, C., & Mouton, Y. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.636 · Cited by 9
Septicémie à Saccharomyces cerevisiae chez un cancéreux
Bonnay, S., Darchis, J., & Veyssier, P. (1991) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(05)80229-x · Cited by 7
Endocarditis infecciosa por levaduras
Úbeda, P., Pérez-Bellés, C., Viudes, A., Pemán, J., Gobernado, M., & Blanes, M. (2001) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(01)72711-5 · Cited by 7
Septic arthritis due to saccharomyces species in a patient with chronic rheumatoid arthritis.
Feld, R. D., Fornasier, V., Bombardier, C., & Hastings, D. E. (1982) · PubMed · Cited by 7
Saccharomyces keratitis and endophthalmitis.
Kirsch, L. S., Brownstein, S., Deschênes, J., Sorgini, C., & Jackson, W. B. (1999) · PubMed · Cited by 5
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Pavèse, P., Brion, J. P., Lebeau, B., Grillot, R., & Ambroise-Thomas, P. (1999) · PubMed · Cited by 4
Research works printed but not linked: 9
- 2001, 11, 19
- Rubinstein, 1975, Medicine, 54, 331
- Eschete, 1980, Archives of Internal Medicine, 140, 1539, 10.1001/archinte.1980.00330220085032 · doi:10.1001/archinte.1980.00330220085032
- 1997, Bulletin de la Soci t de pathologie exotique (1990), 90, 307
- Pavese, 1999, Pathologie-biologie, 47, 579
- Feld, 1982, The Journal of Rheumatology, 9, 637
- Kirsch, 1999, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 34, 229
- Zunic, 1991, Th rapie, 46, 498
- Pletincx, 1995, Journal of pediatric gastroenterology and nutrition, 21, 113, 10.1097/00005176-199507000-00022 · doi:10.1097/00005176-199507000-00022 · Paper page
Cited by
Cohen, S. H., Gerding, D. N., Johnson, S., Kelly, C. P., Loo, V. G., McDonald, L. C., Pepin, J., & Wilcox, M. H. (2010) · Infection Control & Hospital Epidemiology · doi:10.1086/651706 · Cited by 2,942
“boulardii has, however, been associated with fungemia in immunocompromised patients and in patients with central venous lines, and it should be avoided in critically ill patients.(227) There is no compelling evidence that other probiotics are useful in the prevention or treatment of recurrent CDI.”
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Debast, S. B., Bauer, M. P., & Kuijper, E. J. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12418 · Cited by 1,215
“probiotics such as Saccharomyces boulardii in debilitated or immunocompromised patients [134,135].”
BackgroundCandida albicans Biofilms and Human Disease
Nobile, C. J., & Johnson, A. D. (2015) · Annual Review of Microbiology · doi:10.1146/annurev-micro-091014-104330 · Cited by 1,057
Epidemiology of Invasive Mycoses in North America
Pfaller, M. A., & Diekema, D. J. (2010) · Critical Reviews in Microbiology · doi:10.3109/10408410903241444 · Cited by 901
Metadata
- Authors
- Enache-Angoulvant, A., & Hennequin, C.
- Affiliations
- Hôpital Tenon (FR)
- Corresponding author
- Hennequin, C.
- ORCID
- Hennequin, C.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-12-01
- Volume
- 41
- Issue
- 11
- Pages
- 1559-1568
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2168407031
- Cited by
- 369
- References
- 88
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 10 · 2023: 17 · 2022: 14 · 2021: 17 · 2020: 24 · 2019: 19 · 2018: 23 · 2017: 34 · 2016: 19 · 2015: 23 · 2014: 14 · 2013: 23 · 2012: 18
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
- Keywords
- Saccharomyces cerevisiae, Saccharomyces boulardii, invasive candidiasis, fungemia, emerging fungal pathogens, amphotericin B susceptibility, fluconazole, central venous catheters, antibiotic therapy, immunocompetent patient
- MeSH terms
- Female, Humans, Male, Mycoses, Risk Factors, Saccharomyces
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.